                         SEQUENCE LISTING

<110>  VectivBio AG
 
<120>  MANUFACTURE, FORMULATION AND DOSING OF APRAGLUTIDE

<130>  VECT-002/001WO (338004-2011)

<150>  US 63/036,507
<151>  2020-06-09

<150>  US 63/074,119
<151>  2020-09-03

<150>  US 63/157,083
<151>  2021-03-05

<160>  4     

<170>  PatentIn version 3.5

<210>  1
<211>  33
<212>  PRT
<213>  Homo sapiens

<400>  1

His Ala Asp Gly Ser Phe Ser Asp Glu Met Asn Thr Ile Leu Asp Asn 
1               5                   10                  15      


Leu Ala Ala Arg Asp Phe Ile Asn Trp Leu Ile Gln Thr Lys Ile Thr 
            20                  25                  30          


Asp 
    


<210>  2
<211>  33
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  APRAGLUTIDE


<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  Nle

<220>
<221>  MISC_FEATURE
<222>  (11)..(11)
<223>  D-Phe

<400>  2

His Gly Asp Gly Ser Phe Ser Asp Glu Xaa Phe Thr Ile Leu Asp Leu 
1               5                   10                  15      


Leu Ala Ala Arg Asp Phe Ile Asn Trp Leu Ile Gln Thr Lys Ile Thr 
            20                  25                  30          


Asp 
    


<210>  3
<211>  33
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Teduglutide

<400>  3

His Gly Asp Gly Ser Phe Ser Asp Glu Met Asn Thr Ile Leu Asp Asn 
1               5                   10                  15      


Leu Ala Ala Arg Asp Phe Ile Asn Trp Leu Ile Gln Thr Lys Ile Thr 
            20                  25                  30          


Asp 
    


<210>  4
<211>  39
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Glepaglutide

<400>  4

His Gly Glu Gly Thr Phe Ser Ser Glu Leu Ala Thr Ile Leu Asp Ala 
1               5                   10                  15      


Leu Ala Ala Arg Asp Phe Ile Ala Trp Leu Ile Ala Thr Lys Ile Thr 
            20                  25                  30          


Asp Lys Lys Lys Lys Lys Lys 
        35                  


